Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Medtronic
Harvard Business School
Express Scripts
Dow
Julphar
Federal Trade Commission
Baxter
McKinsey
McKesson

Generated: February 21, 2018

DrugPatentWatch Database Preview

Mazindol - Generic Drug Details

« Back to Dashboard

What are the generic sources for mazindol and what is the scope of mazindol freedom to operate?

Mazindol
is the generic ingredient in two branded drugs marketed by Wyeth Ayerst and Novartis, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

Medical Subject Heading (MeSH) Categories for mazindol

US Patents and Regulatory Information for mazindol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis SANOREX mazindol TABLET;ORAL 017247-002 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Novartis SANOREX mazindol TABLET;ORAL 017247-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Wyeth Ayerst MAZANOR mazindol TABLET;ORAL 017980-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Wyeth Ayerst MAZANOR mazindol TABLET;ORAL 017980-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for mazindol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Ayerst MAZANOR mazindol TABLET;ORAL 017980-002 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Novartis SANOREX mazindol TABLET;ORAL 017247-002 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Wyeth Ayerst MAZANOR mazindol TABLET;ORAL 017980-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Novartis SANOREX mazindol TABLET;ORAL 017247-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Dow
Cantor Fitzgerald
Julphar
Colorcon
QuintilesIMS
Harvard Business School
Fuji
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot